Literature DB >> 20053740

Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection.

Michael L Freeman1, Kathleen G Lanzer, Tres Cookenham, Bjoern Peters, John Sidney, Ting-Ting Wu, Ren Sun, David L Woodland, Alessandro Sette, Marcia A Blackman.   

Abstract

Murine gammaherpesvirus 68 (gammaHV68) provides an important experimental model for understanding mechanisms of immune control of the latent human gammaherpesviruses. Antiviral CD8 T cells play a key role throughout three separate phases of the infection: clearance of lytic virus, control of the latency amplification stage, and prevention of reactivation of latently infected cells. Previous analyses have shown that T-cell responses to two well-characterized epitopes derived from ORF6 and ORF61 progress with distinct kinetics. ORF6(487)-specific cells predominate early in infection and then decline rapidly, whereas ORF61(524)-specific cells continue to expand through early latency, due to sustained epitope expression. However, the paucity of identified epitopes to this virus has limited our understanding of the overall complexities of CD8 T-cell immune control throughout infection. Here we screened 1,383 predicted H-2(b)-restricted peptides and identified 33 responses, of which 21 have not previously been reported. Kinetic analysis revealed a spectrum of T-cell responses based on the rapidity of their decline after the peak acute response that generally corresponded to the expression patterns of the two previously characterized epitopes. The slowly declining responses that were maintained during latency amplification proliferated more rapidly and underwent maturation of functional avidity over time. Furthermore, the kinetics of decline was accelerated following infection with a latency-null mutant virus. Overall, the data show that gammaHV68 infection elicits a highly heterogeneous CD8 T-cell response that segregates into two distinctive kinetic patterns controlled by differential epitope expression during the lytic and latency amplification stages of infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053740      PMCID: PMC2826075          DOI: 10.1128/JVI.02229-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.

Authors:  L Liu; E Flaño; E J Usherwood; S Surman; M A Blackman; D L Woodland
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

2.  Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection.

Authors:  P G Stevenson; G T Belz; J D Altman; P C Doherty
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

3.  Early establishment of gamma-herpesvirus latency: implications for immune control.

Authors:  Emilio Flaño; Qingmei Jia; John Moore; David L Woodland; Ren Sun; Marcia A Blackman
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

4.  Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice.

Authors:  P G Stevenson; G T Belz; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  Two complementary methods for predicting peptides binding major histocompatibility complex molecules.

Authors:  K Gulukota; J Sidney; A Sette; C DeLisi
Journal:  J Mol Biol       Date:  1997-04-18       Impact factor: 5.469

6.  Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation.

Authors:  Robert Thimme; Victor Appay; Marie Koschella; Elisabeth Panther; Evelyn Roth; Andrew D Hislop; Alan B Rickinson; Sarah L Rowland-Jones; Hubert E Blum; Hanspeter Pircher
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  CD107a as a functional marker for the identification of natural killer cell activity.

Authors:  Galit Alter; Jessica M Malenfant; Marcus Altfeld
Journal:  J Immunol Methods       Date:  2004-11       Impact factor: 2.303

8.  Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.

Authors:  M A Coppola; E Flaño; P Nguyen; C L Hardy; R D Cardin; N Shastri; D L Woodland; M A Blackman
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

9.  Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells.

Authors:  S Ehtisham; N P Sunil-Chandra; A A Nash
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Lung epithelial cells are a major site of murine gammaherpesvirus persistence.

Authors:  J P Stewart; E J Usherwood; A Ross; H Dyson; T Nash
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  33 in total

Review 1.  CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation.

Authors:  Anthony J St Leger; Robert L Hendricks
Journal:  J Neurovirol       Date:  2011-12-08       Impact factor: 2.643

2.  γ-Herpesvirus reactivation differentially stimulates epitope-specific CD8 T cell responses.

Authors:  Michael L Freeman; Claire E Burkum; Meghan K Jensen; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2012-03-09       Impact factor: 5.422

3.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

4.  In vivo modulation of avidity in highly sensitive CD8(+) effector T cells following viral infection.

Authors:  Beth C Holbrook; Rama D Yammani; Lance K Blevins; Martha A Alexander-Miller
Journal:  Viral Immunol       Date:  2013-08-24       Impact factor: 2.257

Review 5.  Coinfections: Another Variable in the Herpesvirus Latency-Reactivation Dynamic.

Authors:  Tiffany A Reese
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

6.  ATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection.

Authors:  Joseph M Kulinski; Eric J Darrah; Katarzyna A Broniowska; Wadzanai P Mboko; Bryan C Mounce; Laurent P Malherbe; John A Corbett; Stephen B Gauld; Vera L Tarakanova
Journal:  Virology       Date:  2015-05-21       Impact factor: 3.616

7.  Mononucleosis and antigen-driven T cell responses have different requirements for interleukin-2 signaling in murine gammaherpesvirus infection.

Authors:  Michael Molloy; Weijun Zhang; Edward Usherwood
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

8.  Changes in functional but not structural avidity during differentiation of CD8+ effector cells in vivo after virus infection.

Authors:  Samuel Amoah; Rama D Yammani; Jason M Grayson; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

9.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

10.  Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

Authors:  Michael L Freeman; Claire E Burkum; Kathleen G Lanzer; Alan D Roberts; Mykola Pinkevych; Asako Itakura; Lawrence W Kummer; Frank M Szaba; Miles P Davenport; Owen J T McCarty; David L Woodland; Stephen T Smiley; Marcia A Blackman
Journal:  J Autoimmun       Date:  2012-12-14       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.